To hear about similar clinical trials, please enter your email below
Trial Title:
A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients
NCT ID:
NCT06118229
Condition:
Non Small Cell Lung Cancer
Conditions: Official terms:
Carcinoma, Non-Small-Cell Lung
Conditions: Keywords:
Non Small Cell Lung Cancer
Wearable Devices
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Device
Intervention name:
Wearable smart devices and PROs
Description:
Patients wearing wearable smart devices to monitor physiological data while regularly
utilizing PROs to report subjective assessments of their own health status.
Arm group label:
NSCLC patients wearing wearable smart devices
Summary:
The trial was designed as a single-center non-interventional prospective observational
study to explore the role and impact of wearable smart devices in perioperative NSCLC
patients.
Criteria for eligibility:
Study pop:
Continuously enroll all patients with non-small cell lung cancer, histopathologically
confirmed
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
1. Participants must provide voluntary consent to participate in this research and
possess the capacity to sign an informed consent form.
2. Participants must be aged over 18 years.
3. Participants must have undergone pulmonary resection surgery with a postoperative
pathological confirmation of primary lung cancer.
Exclusion Criteria:
1. Patient refusal to participate in this research.
2. Inability to wear wearable smart monitoring devices due to various reasons.
3. The pathological report suggests a non-small cell lung cancer (NSCLC) exclusion.
4. History of secondary lung cancer surgery.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University
Address:
City:
Guangzhou
Country:
China
Status:
Recruiting
Contact:
Last name:
Wenhua Liang, M.D
Phone:
+86-13710249454
Email:
liangwh1987@163.com
Contact backup:
Last name:
Wenhua Liang, M.D
Start date:
March 9, 2023
Completion date:
March 31, 2026
Lead sponsor:
Agency:
The First Affiliated Hospital of Guangzhou Medical University
Agency class:
Other
Source:
The First Affiliated Hospital of Guangzhou Medical University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06118229
